Annual Revenue
$3.63 B
+$402.63 M+12.48%
31 December 2022
Summary:
Horizon Therapeutics Public Limited annual revenue is currently $3.63 billion, with the most recent change of +$402.63 million (+12.48%) on 31 December 2022. During the last 3 years, it has risen by +$1.43 billion (+64.92%). HZNP annual revenue is now at all-time high.HZNP Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$944.96 M
+$112.90 M+13.57%
30 June 2023
Summary:
Horizon Therapeutics Public Limited quarterly revenue is currently $944.96 million, with the most recent change of +$112.90 million (+13.57%) on 30 June 2023. HZNP quarterly revenue is now -8.87% below its all-time high of $1.04 billion, reached on 30 September 2021.HZNP Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$3.64 B
+$68.55 M+1.92%
30 June 2023
Summary:
Horizon Therapeutics Public Limited TTM revenue is currently $3.64 billion, with the most recent change of +$68.55 million (+1.92%) on 30 June 2023. HZNP TTM revenue is now -4.42% below its all-time high of $3.81 billion, reached on 30 June 2022.HZNP TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HZNP Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +64.9% | -8.9% | +23.2% |
| 5 y5 years | +200.5% | +181.7% | +182.1% |
HZNP Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.9% | -8.9% | +13.6% | -4.4% | +23.2% |
| 5 y | 5 years | at high | +200.5% | -8.9% | +181.7% | -4.4% | +182.1% |
| alltime | all time | at high | >+9999.0% | -8.9% | >+9999.0% | -4.4% | >+9999.0% |
Horizon Therapeutics Public Limited Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $944.96 M(+13.6%) | $3.64 B(+1.9%) |
| Mar 2023 | - | $832.06 M(-11.7%) | $3.58 B(-1.5%) |
| Dec 2022 | $3.63 B(+12.5%) | $942.03 M(+1.8%) | $3.63 B(-2.0%) |
| Sept 2022 | - | $925.36 M(+5.6%) | $3.70 B(-2.9%) |
| June 2022 | - | $876.41 M(-1.0%) | $3.81 B(+1.2%) |
| Mar 2022 | - | $885.25 M(-12.7%) | $3.77 B(+16.8%) |
| Dec 2021 | $3.23 B(+46.6%) | $1.01 B(-2.2%) | $3.23 B(+9.1%) |
| Sept 2021 | - | $1.04 B(+24.6%) | $2.96 B(+15.7%) |
| June 2021 | - | $832.55 M(+143.1%) | $2.56 B(+16.9%) |
| Mar 2021 | - | $342.41 M(-54.1%) | $2.19 B(-0.6%) |
| Dec 2020 | $2.20 B(+69.3%) | $745.31 M(+17.1%) | $2.20 B(+21.0%) |
| Sept 2020 | - | $636.43 M(+37.5%) | $1.82 B(+19.8%) |
| June 2020 | - | $462.78 M(+30.0%) | $1.52 B(+10.3%) |
| Mar 2020 | - | $355.91 M(-2.1%) | $1.38 B(+5.8%) |
| Dec 2019 | $1.30 B(+7.7%) | $363.55 M(+8.4%) | $1.30 B(+0.6%) |
| Sept 2019 | - | $335.47 M(+4.6%) | $1.29 B(+0.8%) |
| June 2019 | - | $320.65 M(+14.4%) | $1.28 B(+1.4%) |
| Mar 2019 | - | $280.37 M(-21.1%) | $1.26 B(+4.7%) |
| Dec 2018 | $1.21 B(+14.3%) | $355.54 M(+9.3%) | $1.21 B(+7.2%) |
| Sept 2018 | - | $325.31 M(+7.4%) | $1.13 B(+5.0%) |
| June 2018 | - | $302.83 M(+35.3%) | $1.07 B(+1.3%) |
| Mar 2018 | - | $223.88 M(-18.4%) | $1.06 B(+0.3%) |
| Dec 2017 | $1.06 B(+7.7%) | $274.22 M(+0.9%) | $1.06 B(-3.3%) |
| Sept 2017 | - | $271.65 M(-6.2%) | $1.09 B(+6.1%) |
| June 2017 | - | $289.51 M(+31.1%) | $1.03 B(+3.2%) |
| Mar 2017 | - | $220.86 M(-28.8%) | $997.29 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $981.12 M(+29.6%) | $310.35 M(+48.7%) | $981.12 M(+7.2%) |
| Sept 2016 | - | $208.70 M(-18.9%) | $915.31 M(-1.9%) |
| June 2016 | - | $257.38 M(+25.7%) | $933.15 M(+10.0%) |
| Mar 2016 | - | $204.69 M(-16.3%) | $848.59 M(+12.1%) |
| Dec 2015 | $757.04 M(+154.9%) | $244.54 M(+7.9%) | $757.04 M(+22.8%) |
| Sept 2015 | - | $226.54 M(+31.1%) | $616.35 M(+32.6%) |
| June 2015 | - | $172.82 M(+52.7%) | $464.93 M(+29.8%) |
| Mar 2015 | - | $113.14 M(+9.0%) | $358.17 M(+20.6%) |
| Dec 2014 | $296.95 M(+301.2%) | $103.84 M(+38.2%) | $296.95 M(+33.0%) |
| Sept 2014 | - | $75.13 M(+13.7%) | $223.19 M(+29.6%) |
| June 2014 | - | $66.06 M(+27.2%) | $172.18 M(+46.8%) |
| Mar 2014 | - | $51.93 M(+72.6%) | $117.25 M(+58.4%) |
| Dec 2013 | $74.02 M(+292.8%) | $30.08 M(+24.8%) | $74.02 M(+48.3%) |
| Sept 2013 | - | $24.11 M(+116.6%) | $49.90 M(+54.5%) |
| June 2013 | - | $11.13 M(+28.0%) | $32.30 M(+29.1%) |
| Mar 2013 | - | $8.69 M(+45.9%) | $25.01 M(+32.7%) |
| Dec 2012 | $18.84 M(+172.0%) | $5.96 M(-8.6%) | $18.84 M(+14.8%) |
| Sept 2012 | - | $6.52 M(+69.8%) | $16.41 M(+61.5%) |
| June 2012 | - | $3.84 M(+52.2%) | $10.16 M(+32.7%) |
| Mar 2012 | - | $2.52 M(-28.4%) | $7.66 M(+10.5%) |
| Dec 2011 | $6.93 M(+191.5%) | $3.53 M(+1191.6%) | $6.93 M(+101.9%) |
| Sept 2011 | - | $273.00 K(-79.6%) | $3.43 M(-10.8%) |
| June 2011 | - | $1.33 M(-25.5%) | $3.85 M(-7.7%) |
| Mar 2011 | - | $1.79 M(+5876.7%) | $4.17 M(+75.5%) |
| Dec 2010 | $2.38 M | $30.00 K(-95.6%) | $2.38 M(+1.3%) |
| Sept 2010 | - | $689.00 K(-58.4%) | $2.35 M(+41.6%) |
| June 2010 | - | $1.66 M | $1.66 M |
FAQ
- What is Horizon Therapeutics Public Limited annual revenue?
- What is the all time high annual revenue for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly revenue?
- What is the all time high quarterly revenue for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM revenue?
- What is the all time high TTM revenue for Horizon Therapeutics Public Limited?
What is Horizon Therapeutics Public Limited annual revenue?
The current annual revenue of HZNP is $3.63 B
What is the all time high annual revenue for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual revenue is $3.63 B
What is Horizon Therapeutics Public Limited quarterly revenue?
The current quarterly revenue of HZNP is $944.96 M
What is the all time high quarterly revenue for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly revenue is $1.04 B
What is Horizon Therapeutics Public Limited TTM revenue?
The current TTM revenue of HZNP is $3.64 B
What is the all time high TTM revenue for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM revenue is $3.81 B